Princess Diana captured on CCTV as she left the Ritz Hotel in Paris shortly before her death in a car crash in 1997.[Reuters] The UK government has finally released a heavily redacted official log detailing the events following the death of Princess Diana in 1997.
SAN DIEGO, April 11, 2017 /PRNewswire/-- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that the U.S. Food and Drug Administration (FDA) has approved INGREZZAâ¢ (valbenazine) capsules for the treatment of adults with tardive dyskinesia (TD).
FDA Approves Zarxio. Zarxio is the first biosimilar to be approved in the United States. The United States Food and Drug Administration (FDA) has approved Zarxio (filgrastim-sndz), a leukocyte growth factor biosimilar to the reference product Neupogen. It is indicated for the treatment of neutropenia associated with chemotherapy and all other indications included in the reference product's label.